VKTX | Viking TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$26.09
-$0.74 (-2.76%)

Viking Therapeutics (VKTX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $26.09 vs 50 $30.23 / 200 $32.34
Projection
No cross projected
Test
No active test
Last cross
Death cross 7 Oct 2026 ยท projected 10 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $27.28 vs 50 $32.71 / 200 $33.75
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Death cross week of 5 Oct 2026 ยท projected 21 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $26.56 vs 50 $27.30 / 200 $32.70
Projection
No cross projected
Test
No active test
Last cross
Death cross 16 Sep 2026 ยท projected 23 bars out

Cross history

35
crosses on record since 2017
16 golden19 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
7 Oct 2026Death flatdaily10 bars outNot tested
week of 5 Oct 2026Death flatweekly21 bars outActive Cross Test
16 Sep 2026Death4-hour23 bars outNot tested
3 Sep 2026Golden4-hour6 bars out6 bar cross test
31 Aug 2026Death4-hour6 bars out2 bar cross test

About VKTX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$86.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.